AI Verdict
LEVI has stronger fundamentals based on our AI analysis.
LEVI vs LENZ Fundamental Comparison
| Metric | LEVI | LENZ |
|---|---|---|
| Revenue | $1.7B | $19.1M |
| Net Income | $175.8M | $-82.1M |
| Net Margin | 10.1% | -430.3% |
| ROE | 8.0% | -28.9% |
| ROA | 2.7% | -26.8% |
| Current Ratio | 1.58x | 14.23x |
| Debt/Equity | 0.48x | 0.00x |
| EPS | $0.45 | $-2.85 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LEVI vs LENZ: Frequently Asked Questions
Is LEVI or LENZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LEVI has stronger fundamentals. LEVI is rated BUY (72% confidence) while LENZ is rated STRONG SELL (80% confidence). This is not investment advice.
How does LEVI compare to LENZ fundamentally?
LEVI STRAUSS & CO has ROE of 8.0% vs LENZ Therapeutics, Inc.'s -28.9%. Net margins are 10.1% vs -430.3% respectively.
Which stock pays higher dividends, LEVI or LENZ?
LEVI has a dividend yield of N/A or no dividend while LENZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LEVI or LENZ for long term?
For long-term investing, consider that LEVI has BUY rating with 72% confidence, while LENZ has STRONG SELL rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LEVI vs LENZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LEVI vs LENZ, the AI consensus favors LEVI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.